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(57) ABSTRACT 
Novel sterol/stanol esters of a conjugated fatty acid are 
provided through the esterification or transesterification of a 
sterol such as beta-sitosterol or a hydrogenated form thereof 
(stanol). Such novel esters exhibit the combined properties 
normally possess by the sterol/stanol compound and the 
conjugated fatty acid and as such are excellent additives for 
dietetic foods and supplements. 
10 Claims, No Drawings 
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STEROL ESTERS OF CONJUGATED 
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THEIR PRODUCTION 
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of a sterol or stanol with a conjugated fatty acid, such as 
CLA, there is provided a compound which provides the 
advantages of both the conjugated fatty acid and the sterol 
or stanol. CLA is a liquid fatty acid with two conjugated 
CROSS REFERENCE TO RELATED 
APPLICATION 
This application claims the benefit of my copending U.S. 
provisional application Serial No. 60/160,894, filed Oct. 21, 
1999. 
5 double bonds, therefore, it can reduce the melting point of 
sterols and stanols dramatically. Indeed, the beta-sitosterol 
ester of CLA is liquid at ambient temperature while the 
current commercial products made of the fatty acids derived 
from vegetable oils are solid or semisolid. The sterol ester of 
BACKGROUND OF THE INVENTION 
1. Technical Field 
This invention relates to novel sterol esters of conjugated 
linoleic acids and a process for the production of the same 
by esterification of sterols and stanols with a conjugated 
linoleic acid. 
10 CLA also provides a product having lower total calories than 
the blended product that provides the same doses of sterol 
and CLA. Such new products thus offer the combined 
benefits of sterols/stanols as a cholesterol control agent and 
CLA as an anticarcinogen and fat reducing agent. Such 
15 esters can be used as a supplement or ingredient in foods. 
2. Background 
It is known that the addition of plant sterol (phytosterol) 
In accordance with another embodiment of the present, 
sterol esters can be readily prepared through esterification of 
sterol or stanol with the conjugated fatty acid or by trans-
esterification of sterol or stanol with of the conjugated fatty 
20 acid methyl ester. Transesterification is the preferred method 
to those skilled in the art. 
to diets will reduce serum cholesterol levels. Such additives 
effect the reduction of serum cholesterol through the dis-
ruption of intestinal absorption of dietary cholesterol by 
displacing it from bile and micelli. Free sterols or stanols, 
though, are not optimum candidates for use in typical 
pharmaceutical or dietary dosage forms as cholesterol reduc- 25 
ing agents due to their very high melting points 130 C. and 
low solubility in aqueous and oil media. As a result such 
compounds are preferred to be converted into their fatty 
esters for food applications, which reduce their melting 
points and solubility in oil. However, the fatty acids attached 30 
to sterol in the current commercial products are from veg-
etable oil such as sunflower, canola, or soybean oil. Those 
fatty acids provide no pharmaceutical or nutraceutical func-
tions except increasing the total calories of the products. 
Conjugated fatty acids are known to have many health 35 
benefits such as reducing body fat, inhibiting tumor growth 
and reducing atherosclerosis. Such conjugated fatty acids 
are naturally found in beef and dairy fats in trace amounts 
(0.2-30 mg/g food). One such conjugated fatty acid is 
conjugated linoleic acid ( octadecadienoic acid), hereinafter 40 
referred to as CLA. Cattle convert the linoleic acid in grass 
into CLA by their special digestive processes. However, 
since humans cannot produce such conjugated fatty acids, 
such additives to the human system must be through the diet. 
Thus the providing of CLA in a form to permit its use in 45 
dietetic foods would serve as a significant contribution to the 
field of dietetic foods since it would enable the recipient to 
receive a valuable additive since it is known that CLA is 
effective in increasing body protein or preventing the loss of 
body protein in a human, increasing food efficiency in 50 
humans and assists in reducing body fat. 
A better understanding of the present invention, its several 
aspects, and its advantages will become apparent to those 
skilled in the art from the following detailed description, 
wherein there is shown and described the preferred embodi-
ment of the invention, simply by way of illustration of the 
best mode contemplated for carrying out the invention. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENT 
As used herein the term "sterol ester" includes both the 
plant sterol ester per se as well as the hydrogenated sterol 
products which are referred to as stanol and campestanol. 
Such compounds have the following general formula: 
Ac---C0---0-ST 
wherein Ac-CO is an acyl group from a conjugated fatty 
acid and O-ST is a steryl group derived from a sterol/ 
stanol. 
The term "conjugated fatty acid" is intended to refer to 
conjugated linoleic acid (CLA) which in turn refers to a 
group of geometrical and positional isomers of linoleic acids 
including but not limited to 9,11-octadecadienoic acid, and 
10---12 octadecadienoic acid. The cis-9, trans-11 isomer is 
the most dominant isomer of CLA in dairy products and is 
also the most biologically active form as known at present. 
The term "sterol" or "sterol/stanol" as used herein is 
intended to mean the sterol compound per se or its hydro-
genated form including stanol and campestanol. 
The present invention is based upon my discovery that 
through the use of the conjugated fatty acid-CLA-in the 
esterification of a sterol there is obtained a product which is 
liquid at ambient temperature and which product has lower 
total calories and which product provides the combined 
It is thus an object of the present invention to provide a 
novel ester composition consisting essentially of phytoster-
ols including plant sterols/stanols and conjugated linoleic 
acids. 
Another object of this invention is to prepare sterol and 
stanol esters of CLA for their utilization in food and dietary 
supplement products. 
55 benefits of cholesterol control agent and an anticarcinogen 
and fat reducing agent. 
Another object of the present invention is to provide a 
process for the production of sterol esters of conjugated 
linoleic acids through transesterification and/or esterifica-
tion. 
SUMMARY OF THE INVENTION 
In accordance with one embodiment of the present 
invention, I have discovered that through the esterification 
The present invention provides a process for esterfying 
stanols or/and sterols with CLA. This esterification reaction 
may be accomplished either through the reaction of the 
60 sterol with CLA using a esterification catalyst such as 
sulphonic acids and tin chloride or though the reaction of the 
sterol with CLA methyl ester using a transesterification 
catalyst such as sodium methoxide and hydroxide. The 
results of those esterification reactions is a sterol ester of 
65 CLA or a stanol ester of CLA. 
While any stanol or sterol that is functionalized with a 
hydroxy group is suitable for transesterification and esteri-
US 6,413,571 Bl 
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fication by the processes as described herein, in one pres-
ently preferred embodiment of the present invention there is 
utilized a sterol/stanol selected form the group consisting of 
beta-sitosterol, campesterol, stigmasterol and sitostanol. 
Other suitable sterols include but not limited to 
brassicasterol, avenasterol, alpha-spinasterol and ergosterol. 
It is understood that those sterols/stanols for esterifying may 
be used in pure form or mixed in certain ratios. 
Likewise while any isomer of a conjugated linoleic acid 
is suitable for esterification by the process as described 
herein, in one presently preferred embodiment of the present 
invention there is utilized a conjugated linoleic acid selected 
4 
from the group consisting of cis-9, trans-11-conjugated 
linoleic acid and trans-10, cis 12-conjugated linoleic acid. 
The acid-catalyzed esterification reaction of sterol with 
CLA and base-catalyzed transesterification reaction of sterol 
5 with CLA methyl ester, respectively, are depicted below demonstrating the formation of a sterol ester of CLA per the 
present invention. As shown in the reaction mechanism on 
the left sterol is reacted with CLA in the presence of an acid 
catalyst to produce sterol ester of CLA. In the reaction 
mechanism on the right (which represents the preferred 
10 mechanism), sterol is reacted with CLA methyl ester to 





cis 9, trans 11-conjugated linoleic acid 
H3C 






cis 9, trans 11-linoleic acid phytosterol ester 
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R is defined as following alkyl or alkenyl groups: 





(no double bond at 5, 6) 
Brassicasterol: -CH(CH3)CH=CHCH2CH(CH3)2 
Avenasterol: -CH(CH3)CH2CH2C(=CH-CH3)CH 10 
(CH3)2 (double bond at 5, 6 or 7, 8 only) 
alpha-Spinasterol: -CH(CH3)CH=CHCH2C(C2H5) 
CH(CH3)2(double bond at 7, 8) 
Ergosterol: -CH(CH3)CH=CHCH(CH3)CH(CH3)2 
(double bonds at 5, 6 and 7, 8) 15 
A similar reaction system is carried out when the hydro-
genated sterol such as stanol is the reactant. 
The molar ratios of the starting materials for the transes-
terification and esterification reactions are provided in sto-
ichiometric levels. It is preferred that the CLA be present in 20 
at least 5-10% excess so as to react with all of the sterol or 
stanol. Any excess unreacted CLA is easily removed in the 
product work-up. 
The usage of esterification catalyst varies with the catalyst 
used and their uses are reviewed in Bailey's Industrial Oil 25 
and Fat Products, 4th edition, edited by Daniel Swem, 
Volume 2, PP 113-127. Since esterification involves high 
reaction temperature and low reaction rate, sterol ester of 
CLA are preferred to be prepared via transesterification. 
In carrying out the process of the present invention 30 
solvents such as ethers and short chain alkanes may be added 
to the reaction mixture to promote reaction. 
The reaction rate of transesterification increases at an 
elevated temperature. The typical reaction temperature 
ranges from 40 C. to about 250 C. The reaction period may 35 
vary widely, but as a general practice a reaction time in the 
range of about 4 to about 20 hours can be utilized. The 
reaction is normally carried out for a time which will permit 
the reaction to go to completion so that the sterol or stanol 
present is completly esterified. Normally the ester product is 40 
obtained in yields of greater than 95%. 
Following completing of the reactions, the resulting ester 
product can be isolated with or without organic solvent 
extraction after removing the catalyst such as by water 
washing. Typical solvents are low boiling point organic 45 
compounds including but not limited to diethyl or petroleum 
ethers, hexane, dichloromethance, chloroform, and toluene. 
The following examples are intended to be illustrative of 
the present invention and to teach one of ordinary skill in the 
art to make and use the invention. These examples are not 50 
intended to limit the invention in any way. 
EXAMPLE 1 
8 
the reaction was continued under a high vacuum up to 0.01 
mm Hg and the temperature was raised gradually to 110 C. 
The reaction continued until no methanol was bubbling, then 
the mixture was cooled down to about 60 C. before breaking 
the vacuum with N2 . 6 grams of warm water (40-50 C.) was 
added to destroy the catalyst. The mixture was stirred for 
about 1 minute until appearing homogenous and then cen-
trifuged at 5000 G for 5 minutes. The top layer containing 
sterol esters was collected and washed with 12 g warm 
water. The mixture was then centrifuged to recover the top 
sterol ester layer. The sterol ester was then purified by 
vacuum distillation to remove moisture and residual methyl 
esters. The product is liquid at ambient temperature and has 
three melting peaks at 15, 37, and 58 C. as measured by 
DSC. 
EXAMPLE 2 
To Prepare Sterol Esters from Conjugated Linoleic Acid 
CLA One TM, a commercial CLA product available from 
Pharmanutrients, Inc. and which contains 75% of free fatty 
acid, was used in this synthesis. CLA One TM typically 
contains with 35% cis 9, trans 11 and 36% trans 10, cis 
12-linoleic acids. 150 g of CLA One TM was mixed with 600 
mL methanol and 12 mL concentrated sulfuric acid. The 
mixture was refluxed for 30 minutes to prepare the methyl 
esters of fatty acids. The product was washed twice with 100 
mL 5% sodium chloride and with 2% potassium bicarbonate 
until nutral pH in the aqueous phase. The methyl esters of 
fatty acids were dried by heating at 90-105 C. under up to 
20 mm Hg vacuum. One hundred grams of methyl ester 
produced as above was mixed with 60 g plant sterols that 
contains 40% beta-sitosterol, 20-30% campesterol and 
10---30% dihydrobrassicasterol. The mixture was dried at 
90---105 C. under up to 20 mm Hg vacuum for about an hour. 
After cooling the mixture down below 70 C., 0.5 grams of 
NaOCH3 powder was added to the reactant mixture as 
transesterification catalyst. Vacuum was applied slowly to 
remove the methanol produced so the reaction proceeded to 
the direction forming sterol esters. When vigorous bubbling 
ceased, the reaction was continued under a high vacuum up 
to 0.01 mm Hg and the temperature was raised gradually to 
110 C. The reaction continued until no methanol was bub-
bling out. The mixture was cooled down to about 60 C. and 
nitrogen was introduced to break the vacuum. 6 grams of 
50% citric acid aqueous solution was added to neutralize the 
transesterification catalyst. The mixture was stirred for about 
6 minutes or until appearing homogenous and then centri-
fuged at 4000 G for 5-30 minutes. The top layer containing 
sterol esters was collected and washed twice with 12 g warm 
water. The mixture was then centrifuged at 4000 G for 5 
minutes to recover the top sterol ester layer. The sterol ester 
was then purified by vacuum distillation to remove moisture 
and residual methyl esters. 
The specific examples herein disclosed are to be consid-
ered as being primarily illustrative. Various changes beyond 
those described will not doubt occur to those skilled in the To Prepare Sterol Esters from Conjugated Linoleic Acid 
Methyl Ester 55 art and such changes are to be understood as forming a part 
of this invention insofar as they fall within the spirit and 
scope of the appended claims. 
A commercial CLA methyl ester product was used in the 
synthesis, which contains 41 % of cis 9, trans 11, 44% of 
trans 10, cis 12, and 10% of cis 10, cis 12 conjugated linoleic 
acids. 60 grams of plant sterols containing 40% beta-
sitosterol, 20---30% campesterol and 10-30% dihydrobrassi- 60 
casterol was mixed with 100 grams of CLA methyl ester. 
The mixture is solid at room temperature. After dried at 
90-105 C. under about 20 mm Hg vacuum for about an hour, 
the mixture was cooled down to about 70 C., and 1.3 grams 
of 25% NaOCH3-Methanol solution was added. A vacuum 65 
of up to 20 mm Hg was applied slowly to remove the 
methanol produced. When no vigorous bubbles came out, 
The inventive compositions are usable as a component in 
any number of food products or as a dietary supplement 
whereby the compositions may be delivered in a convenient 
form and the advantages thereof may be easily obtained. 
What is claimed is: 
1. A process for the production of sterol or stanol esters of 
a conjugated linoleic acid which comprises reacting under 
conditions suitable for effecting transesterification an alco-
hol ester of a conjugated linoleic acid and a sterol or stanol 
in the presence of a transesterification catalyst. 
US 6,413,571 Bl 
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2. A process in accordance with claim 1 wherein said 
conjugated linoleic acid is selected from the group consist-
ing of cis-9, trans-11-conjugated linoleic acid and trans-10, 
cis-12-conjugated linoleic acid. 
3. A process in accordance with claim 2 wherein said 
conjugated linoleic acid is cis-9, trans-11 conjugated linoleic 
acid. 
4. A process in accordance with claim 3 wherein said 
conjugated linoleic acid is trans-10, cis-12-conjugated 
5 
linoleic acid. 10 
5. A process in accordance with claim 1 wherein said 
sterol is selected from the group consisting of beta-
sitosterol, campesterol, stigmasterol, sitostanol, and 
campestanol. 
10 
6. A process in accordance with claim 5 wherein said 
sterol is beta-sitosterol. 
7. A process in accordance with claim 5 wherein said 
sterol is campesterol. 
8. A process in accordance with claim 5 wherein said 
sterol is stigmasterol. 
9. A process in accordance with claim 5 wherein said 
sterol is sitostanol. 
10. A process in accordance with claim 5 wherein said 
sterol is campestanol. 
* * * * * 
